Novel Influenza Vaccine
Walter Gerhard and Laszlo Otvos
Any vaccine that produces broad immunity against influenza A would be a significant improvement over the current strain-specific vaccines that must be produced anew each year. Additionally, this vaccine would be produced synthetically, which is a major improvement over the current methods of growing influenza vaccine in fertilized eggs.
This technology is available for exclusive license.
Mozdzanowska, et al., Vaccine, 21, 2616-2626. 2003.